LOG IN
|
Services
|
Contact
|
Custom Research
Search
Advanced search
Main
Healthcare, Pharmaceuticals & Biotechnology
Healthcare and drugs
U.S. Molecular Diagnostics Markets
Publications
Business, Finance & Insurance
(35706)
Consumer Goods & Retail
(127031)
Databases & Statistics
(27)
Education & Consulting
(0)
Industry
(87698)
Healthcare, Pharmaceuticals & Biotechnology
(58540)
Biotechnology
(9100)
Pharmaceuticals
(30490)
Healthcare and drugs
(18950)
Services
(0)
Government and Public Sector
(553)
Technologies & Electronics
(91477)
Company reports
(70860)
Country reports
(2187)
(Currently 512486 Items)
Partners
Healthcare and drugs / REPORT INFORMATION
U.S. Molecular Diagnostics Markets
Date
Jun, 2003
Pages
0
Price / format
€3353 / Hard Copy
€2976 / Site License
€4106 / Enterprisewide
€2 951
Report Information
|
Custom-Tailored Research
|
Product Trade Lead
Abstract:
Emerging Technologies and Expanded Applications of Existing Products Will Drive Market Growth
The use of molecular-based diagnostic solutions is expanding to other diseases. For example, the viral load monitoring and genotyping techniques that have increased the life expectancy of HIV-infected patients, have led to their emergence as valuable tools for the management of hepatitis C.
The market for molecular diagnostics includes an extensive list of innovative products and testing solutions. New developments such as gene sequencing and nucleic acid amplification have revolutionized the in vitro diagnostics industry. The future success of these companies depends on the speed at which they can find expanded applications for assays. Increasing insight into the ways in which genes influence a pathogen's response to therapy is ensuring tremendous growth in pharmacogenomics. Collaborations between diagnostic and pharmaceutical companies are expected to drive sales of both products.
This study examines the competitive factors in the dynamic U.S. molecular diagnostics market, and highlights the growth of the cancer diagnostics and pharmacogenomics sectors. Each challenge and strategy is described in detail, and industry trends have been evaluated through extensive interviews with industry participants.
Limited Reimbursements by Third-party Payers Obstruct Sales
The sale of novel diagnostic products is hampered by the lack of third-party reimbursements, since this dissuades healthcare professionals from investing in them. There is a significant gap from the date of approval of a new test to the implementation of acceptable reimbursement schedules. This results in higher product prices that affect sales. Also, funding organizations lack the incentive to increase reimbursement rates as long as the economic advantages of the newer tests over established procedures is unclear. To increase acceptance among the healthcare community, diagnostic manufacturers are compelled to offer their products at close to, or less than, cost prices. Since reimbursement rates are not keeping pace with costs, this is hindering the development and availability of FDA-approved testing solutions.
Flexibility and Sensitivity of Molecular Techniques Encourages Their Use as Diagnostics
Products based on molecular techniques enjoy increased sensitivity and specificity over traditional immunodiagnostic tests, says the analyst of this research service. Molecular-based diagnostics are finding increasing uses in genotyping, viral load monitoring, and single nucleotide polymorphism detection. This has led to molecular diagnostic products becoming vital components of disease prevention, management, and treatment.
Innovative molecular-based diagnostic solutions have provided healthcare professionals with valuable data unobtainable by other means. Current trends merge the benefits of assays and drugs, and allow them to work synergistically in the treatment of disease, adds the analyst. The implementation of nucleic acid testing reduces the time lag between infection and detection to half that taken by traditional immunoassays.
Additional Information
The following technologies are covered in this research:
Genotyping: Genotyping is a method of studying and monitoring the changes in genetic information, a genome-wide approach to gene mapping
Viral Load Monitoring: Viral load monitoring is a method of determining the concentration of virus in a patient’s blood
Single Nucleotide Polymorphisms (SNP): SNP is a mutation event where a single DNA nucleotide is replaced by another nucleotide
Molecular Diagnostics: Molecular Diagnostics are assays and tests that detect the DNA or RNA for diagnosis
Table of contents:
1 EXECUTIVE SUMMARY
Executive Summary
1. Executive Summary
2 TOTAL MARKET
Market Overview
1. Introduction
2. Research Methodology
Market Segmentation and Revenue Forecast
1. Market Segmentation
2. Revenue Forecast
Challenges and Strategies
1. Market Challenges
2. Strategic Recommendations
Frost & Sullivan Awards
1. Product Innovation Award
2. Technology Innovation Award
3. Product Line Quality Award
4. Technology Leadership Award
3 INFECTIOUS DISEASE
Market Overview
1. Introduction
2. Analysis
Drivers Restraints and Trends
1. Market Drivers
2. Market Restraints
3. Market and Technology Trends
Competitive Structure and Revenue Forecast
1. Competitive Structure
2. Revenue Forecast
MRSA - Emerging Market
1. Introduction
2. Market Potential
3. Diagnostic Solutions
SARS - Emerging Market
1. Introduction
2. Market Potential
3. Diagnostic Solutions
4 CANCER DIAGNOSTICS
Market Overview
1. Introduction and Definitions
2. Analysis
Drivers Restraints and Trends
1. Market Drivers
2. Market Restraints
3. Technology Trends
Demand Product and Pricing Analysis
1. Demand Analysis
2. Product and Pricing Analysis
Competitive Structure and Revenue Forecasts
1. Competitive Structure
2. Revenue Forecasts
5 PHARMACOGENOMICS
Market Overview
1. Introduction
2. Analysis
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market and Technology Trends
Demand Products and Pricing Analysis
1. Demand Analysis
2. Product and Pricing Analysis
Competitive Structure Revenue Forecast
1. Selected Market Players
2. Competitive Structure
3. Revenue Forecast
Order this report
Company name:
Contact person:
Phone/fax:
Email:
Comments:
Product Trade Lead
0 leads found
Add New Buy/Sell Lead
Type:
Buy
Sell
Offer:
Contacts:
Capture:
© 2007-2010 MarketReportFinder.com